150 related articles for article (PubMed ID: 16224506)
1. Systemic side effects from topical imiquimod.
Hanger C; Dalrymple J; Hepburn D
N Z Med J; 2005 Oct; 118(1223):U1682. PubMed ID: 16224506
[No Abstract] [Full Text] [Related]
2. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study.
Vun Y; Siller G
Australas J Dermatol; 2006 Aug; 47(3):169-71. PubMed ID: 16866996
[TBL] [Abstract][Full Text] [Related]
3. Permanent facial hypopigmentation following treatment with imiquimod cream.
Mendonça CO; Yates VM
Clin Exp Dermatol; 2006 Sep; 31(5):721-2. PubMed ID: 16780500
[No Abstract] [Full Text] [Related]
4. Imiquimod and pulmonary embolism: a case report.
Leroy B; Richez A; Wolf F; Descotes J; Vial T
Therapie; 2014; 69(2):180-1. PubMed ID: 24926639
[TBL] [Abstract][Full Text] [Related]
5. Treatment of facial superficial basal cell carcinomas with imiquimod 5% cream.
Mirza B; De'Ambrosis B
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():16-8. PubMed ID: 14616806
[TBL] [Abstract][Full Text] [Related]
6. What lies beneath? A lesson for the clinician. Intraoperative frozen section appearance of persistent basal cell carcinoma after apparent cure with imiquimod 5% cream.
Sukal SA; Mahlberg MJ; Brightman L; Daniel DR; Mintzis MM; Geronemus RG
Dermatol Surg; 2009 Nov; 35(11):1831-4. PubMed ID: 19691665
[No Abstract] [Full Text] [Related]
7. Successful treatment of basal cell carcinoma on the face with imiquimod 5% cream.
Oster-Schmidt C; Altmeyer P; Stücker M
Acta Derm Venereol; 2002; 82(6):477. PubMed ID: 12575864
[No Abstract] [Full Text] [Related]
8. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
Neville JA; Williford PM; Jorizzo JL
J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
[TBL] [Abstract][Full Text] [Related]
9. The treatment of basal skin carcinomas in two sisters with xeroderma pigmentosum.
Roseeuw D
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():30-2. PubMed ID: 14616810
[TBL] [Abstract][Full Text] [Related]
10. Localized pemphigus foliaceus induced by topical imiquimod treatment.
Lin R; Ladd DJ; Powell DJ; Way BV
Arch Dermatol; 2004 Jul; 140(7):889-90. PubMed ID: 15262711
[No Abstract] [Full Text] [Related]
11. The treatment of basal cell carcinomas in a patient with xeroderma pigmentosum with a combination of imiquimod 5% cream and oral acitretin.
Giannotti B; Vanzi L; Difonzo EM; Pimpinelli N
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():33-5. PubMed ID: 14616811
[TBL] [Abstract][Full Text] [Related]
12. Multiple and clustered eruptive epidermoid cysts following treatment with topical imiquimod.
Nasca MR; De Pasquale R; Micali G
Dermatology; 2007; 215(4):352-3. PubMed ID: 17911995
[TBL] [Abstract][Full Text] [Related]
13. Multiple basal cell carcinomas after radiation treatment: successful treatment with topical imiquimod.
Santiago Sánchez-Mateos D; Goiriz Valdés R; Daudén Tello E
Clin Exp Dermatol; 2010 Mar; 35(2):199-200. PubMed ID: 19486047
[No Abstract] [Full Text] [Related]
14. Eruptive epidermoid cysts resulting from treatment with imiquimod.
Marty CL; Randle HW; Walsh JS
Dermatol Surg; 2005 Jul; 31(7 Pt 1):780-2; discussion 782-3. PubMed ID: 16029707
[TBL] [Abstract][Full Text] [Related]
15. Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome.
Vereecken P; Monsieur E; Petein M; Heenen M
J Dermatolog Treat; 2004 Apr; 15(2):120-1. PubMed ID: 15204165
[No Abstract] [Full Text] [Related]
16. Vasodilatory adverse events associated with topical imiquimod 5 percent cream.
Jacobs AA; Snavely N; Markus J; Rosen T
Dermatol Online J; 2008 Apr; 14(4):4. PubMed ID: 18627726
[TBL] [Abstract][Full Text] [Related]
17. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
Vidal D; Matías-Guiu X; Alomar A
Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
[TBL] [Abstract][Full Text] [Related]
18. 'Rub on' treatment for basal-cell carcinoma.
Kerr C
Lancet Oncol; 2002 Apr; 3(4):201. PubMed ID: 12067676
[No Abstract] [Full Text] [Related]
19. Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNalpha-2b and topical imiquimod 5% cream.
Turan A; Saricaoglu H; Baskan EB; Toker SC; Tunali S
Int J Dermatol; 2009 Feb; 48(2):214-5. PubMed ID: 19200213
[No Abstract] [Full Text] [Related]
20. Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: a 3-year follow-up study.
Choontanom R; Thanos S; Busse H; Stupp T
Graefes Arch Clin Exp Ophthalmol; 2007 Aug; 245(8):1217-20. PubMed ID: 17345092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
